Newsletter of MEDICA | View in browser | Deutsch | Print
Header of MEDICA Newsletter

Tumor profiling and the internal clock: the optimal cancer therapy

Dear Sir or Madam,

Every year, people are confronted with a diagnosis of cancer. Tumor profiling is important for optimal treatment. Usually, the analysis is based on a tissue sample. But this is not possible for all patients. Here, a blood test from the University Hospital Zurich offers an alternative. Find out how it works in our interview.

Prof. Angela Relógio, CEO of the start-up TimeTeller, explained to us how the subsequent intake of medication can be optimized and why the internal clock plays a role in this.

Enjoy reading!

Anne Hofmann
Editorial team MEDICA-tradefair.com

Table of Contents

Interview: TimeTeller shows what makes the body tick
MEDICA DEEP DIVE – We. Talk. Healthcare.
Interview: Blood test to determine the optimal cancer therapy
Newsletter Service
Image: Banner with the text: MEDICA Magazine – 365 days a year; Copyright: Messe Düsseldorf

TimeTeller shows what makes the body tick

Interview – LAB & DIAGNOSTICS

Image: Scattered pills on a clock; Copyright: rawf8
Using the internal clock to optimize chemotherapies in cancer treatment - that is the goal of the start-up TimeTeller. If the drugs are administered at the ideal time of day for chemotherapy, it can reduce side effects and improve the effect. TimeTeller has developed a method for determining the internal clock to make this possible.
Click here for the interview
TimeTeller shows what makes the body tick
Read all content from the experience world LAB & DIAGNOSTICS in the MEDICA Magazine here
To top

MEDICA DEEP DIVE – We. Talk. Healthcare.

Hot Topic 2023

Image: MEDICA Deep Dive Logo; Copyright: Messe Düsseldorf
Innovation cycles in healthcare are becoming shorter due to the progress of digitalization, and knowledge is becoming more fast-moving. With MEDICA DEEP DIVE, we are giving trends and insights a stage even before MEDICA in November - live online on your screen. In our 45-minute panel discussions, our experts will show you in detail what opportunities digitization in healthcare is creating - from AI and Big Data to networking, smart hospitals and robotics.
Experience use cases and best practices in our live online talks
MEDICA DEEP DIVE
To top

Molecular tumor profiling: blood test to determine the optimal cancer therapy

Interview – LAB & DIAGNOSTICS

Image: A woman in a laboratory taking blood samples; Copyright: Prostock-studio
If a tumor is diagnosed, tissue samples are usually investigated to determine the molecular tumor profile for personalized cancer treatment. However, tissue biopsy cannot be performed in all affected individuals. Therefore, the University Hospital Zurich has licensed a liquid biopsy for the analysis of more than 300 genes from the company Foundation Medicine/Roche and offers this test as a modern diagnostic method to tumor patients. In our interview, Dr. Martin Zoche explains what insights a liquid biopsy can provide.
Click here for the interview
Molecular tumor profiling: blood test to determine the optimal cancer therapy
Read all content from the experience world LAB & DIAGNOSTICS in the MEDICA Magazine here
To top

NOVA project: next generation of antimicrobial coating technologies

News

DISPOSABLES

Researchers develop and test highly efficient, environmentally friendly and stable antimicrobial (antibacterial, antiviral, antifungal) coating technologies in the NOVA project.
read more
To top

AI against bowel cancer: research project DECADE

News

DIGITAL HEALTH

The DECADE research project is the first to use swarm learning in cancer research. The German Cancer Aid is funding the joint project of several university hospitals with around 1.5 million euros.
read more
To top

Digital patient model: decision support for physicians and cost-saver

News

DIGITAL HEALTH

New perspectives for the healthcare sector: The support system for decision-making developed as part of the MED²ICIN project should increase the treatment success rate. It supports physicians in their decision-making process by pooling all of the information on an individual patient and comparing this to that of cohorts made up of similar individuals.
read more
To top

Digitization, AI, robotics: how healthcare will change over the next 50 years

News

DIGITAL HEALTH

A study by researchers at Mälardalen University (MDU) describes what our future healthcare industry may look like.
read more
To top

Chatbots like ChatGPT: approval as medical devices

News

DIGITAL HEALTH

The new Nature Medicine paper by Prof. Stephen Gilbert, et. al. addresses one of the most pressing international issues of our time: How to regulate Large Language Models (LLMs) in general and specifically in health.
read more
To top

AI supports rehabilitation after spinal cord injury

News

PHYSIO TECH

An intelligent suit is hoped to significantly improve rehabilitation after a serious spinal cord injury. The AI-supported solution will be developed over the next three years by researchers from Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) working in collaboration with Heidelberg University and Heidelberg University Hospital.
read more
To top

Product News, MED TECH & DEVICES

MINI-DATA-BOX

OKW Odenwälder Kunststoffwerke Gehäusesysteme GmbH

read more
Small yet robust enclosures are needed for the integration of miniaturised electronic components, sensors and radio technology. The MINI-DATA-BOX range of plastic enclosures by OKW Gehäusesysteme GmbH...
To top

Product News, MED TECH & DEVICES

EMC SHIELDING

OKW Odenwälder Kunststoffwerke Gehäusesysteme GmbH

read more
Medical electronics have to meet higher and higher standards, and the applications are becoming increasingly complex; particularly in the health sector, trouble-free operation is essential and may...
To top

Product News, MED TECH & DEVICES

SOFT-TOUCH LACQUER

OKW Odenwälder Kunststoffwerke Gehäusesysteme GmbH

read more
Devices can be improved by means of colours and surface finishes. As a customisation option, we therefore offer a wide selection of lacquers to enhance your devices. There are various reasons for...
To top

Newsletter Service

You like our newsletter? Then please recommend us: Forward this newsletter or the link www.MEDICA.de/news_login_2 to your friends and colleagues.

If you have difficulties with your order, please write an e-mail to redaktion@medica.de.

To top
Legal disclaimer

Messe Düsseldorf GmbH
Messeplatz, Stockumer Kirchstr. 61
40474 Düsseldorf, Germany

Phone: +49 211 4560-01
Fax: +49 211 4560-668
www.messe-duesseldorf.de
info@messe-duesseldorf.de

County Court Düsseldorf HRB 63

Board of Managing Directors: Wolfram N. Diener (Chairman), Bernhard J. Stempfle, Erhard Wienkamp

Chairman of Supervisory Board: Mayor Dr. Stephan Keller

Messe Düsseldorf GmbH processes personal data relating to you. You can find more information - also on your rights - in the privacy policy of Messe Düsseldorf GmbH available at www.messe-duesseldorf.de/privacy. In principle, i.e. subject to legal restrictions, you may at any time object to the processing of your personal data either on the aforementioned website, via e-mail to privacy@messe-duesseldorf.de or via postal mail to Messe Düsseldorf GmbH, G2-RV, PF 101006, 40001 Düsseldorf, Germany.

Facebook X LinkedIn YouTube

Should you no longer wish to receive our newsletter, please click here.